CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Anti-TNF Alpha Therapy: A Novel Okt3-Sparing Immunosuppressive Principle For Steroid-Resistant Severe Acute Rejection After Intestinal Transplantation
DOI 10.1055/s-2005-920414
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Pascher, S Kohler, JM Langrehr, AU Dignass, P Neuhaus
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The experience with the rescue treatment of OKT3-resistant rejection and the OKT3-sparing application of anti- TNF alpha therapy using a monoclonal chimeric anti-TNF alpha antibody is presented. Methods: Intestinal transplantation (ITx) was performed in 13 adult patients for irreversible short bowel syndrome. Four patients received an infliximab-rescue therapy (chimeric monoclonal anti-TNF alpha antibody; appr…
Zitieren
Zitierempfehlung
A Pascher, S Kohler, JM Langrehr, AU Dignass, P Neuhaus (2006) Anti-TNF Alpha Therapy: A Novel Okt3-Sparing Immunosuppressive Principle For Steroid-Resistant Severe Acute Rejection After Intestinal Transplantation. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-920414
Mit CareLit weiterarbeiten